UBS Group’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,432
| Closed | -$1.7K | – | 8685 |
|
|
2024
Q3 | $1.7K | Sell |
1,432
-85,221
| -98% | -$101K | ﹤0.01% | 7353 |
|
|
2024
Q2 | $121K | Buy |
86,653
+85,106
| +5,501% | +$119K | ﹤0.01% | 4915 |
|
|
2024
Q1 | $3.68K | Hold |
1,547
| – | – | ﹤0.01% | 6539 |
|
|
2023
Q4 | $5.71K | Buy |
1,547
+1,458
| +1,638% | +$5.38K | ﹤0.01% | 6558 |
|
|
2023
Q3 | $275 | Sell |
89
-904
| -91% | -$2.79K | ﹤0.01% | 7483 |
|
|
2023
Q2 | $2.05K | Buy |
+993
| New | +$2.05K | ﹤0.01% | 6732 |
|
|
2023
Q1 | – | Sell |
-3,751
| Closed | -$8.82K | – | 8498 |
|
|
2022
Q4 | $8.82K | Sell |
3,751
-1,437
| -28% | -$3.38K | ﹤0.01% | 7532 |
|
|
2022
Q3 | $17K | Buy |
5,188
+4,726
| +1,023% | +$15.5K | ﹤0.01% | 6491 |
|
|
2022
Q2 | $2K | Sell |
462
-1,494
| -76% | -$6.47K | ﹤0.01% | 8466 |
|
|
2022
Q1 | $10K | Buy |
1,956
+1,383
| +241% | +$7.07K | ﹤0.01% | 7341 |
|
|
2021
Q4 | $6K | Buy |
+573
| New | +$6K | ﹤0.01% | 8128 |
|